Skip to content

Medical emergency? What to do

Study finds body's potential universal flu defense

3-RXPublished June 30, 20103 min read

Key points

  • The human body makes rare antibodies effective against all flu viruses and these might be boosted to design a better universal flu treatment, researchers reported on Monday.
  • "The ability of these antibodies to protect mice from highly lethal strains of influenza is encouraging," said Yoshihiro Kawaoka, a flu expert at the University of Wisconsin-Madison and University of Tokyo who worked on the study, said in a statement.
  • H1N1 swine flu is still spreading globally, having caused the first pandemic of the 21st century.
  • And new strains could move into the human population any time - including the highly lethal but still rare H5N1 bird flu, which has killed 295 of 499 people infected since 2003.

The human body makes rare antibodies effective against all flu viruses and these might be boosted to design a better universal flu treatment, researchers reported on Monday.

Tests on mice suggest these immune system proteins could help most people survive a normally lethal dose of flu virus, the team at the University of Wisconsin and Seattle-based Theraclone Sciences said.

"The ability of these antibodies to protect mice from highly lethal strains of influenza is encouraging," said Yoshihiro Kawaoka, a flu expert at the University of Wisconsin-Madison and University of Tokyo who worked on the study, said in a statement.

"Such antibodies may be especially useful during outbreaks of newly emerging, highly pathogenic influenza viruses."

H1N1 swine flu is still spreading globally, having caused the first pandemic of the 21st century. While it is a relatively mild strain, it has killed far more children and young adults than flu usually kills and could easily mutate into a more virulent form.

Regular seasonal flu does its own share of damage, killing 250,000 to 500,000 people globally in an average year, according to the World Health Organization.

And new strains could move into the human population any time - including the highly lethal but still rare H5N1 bird flu, which has killed 295 of 499 people infected since 2003.

Privately owned Theraclone identified the antibodies using a technology it has to screen for rare but useful antibodies. The company then contracted with the researchers to make large quantities of these antibodies and test them in mice.

The antibodies attack a part of the flu virus that all or most strains seem to have, without a lot of mutations.

Writing in the Proceedings of the National Academy of Sciences, the researchers said when they infected mice treated with the antibodies with deadly doses of H1N1 and H5N1 flu, 60 percent to 80 percent recovered, compared to just 10 percent of untreated animals.

It may be possible to engineer better versions of the antibodies in the lab - so called monoclonal antibodies - to make a good alternative treatment for dangerous flu infections, the researchers said.

Four drugs are currently on the market to treat flu - Roche AG and Gilead Sciences Inc's Tamiflu, GlaxoSmithKline and Biota's Relenza, and the two older drugs amantadine and rimantadine.

But flu viruses almost all resist the effects of the older drugs and several strains of seasonal flu have mutated into forms that cannot be helped by Tamiflu. And Relenza and Tamiflu must be given within the first two days of infection to be really helpful.

So scientists are looking for new and better treatments.

Theraclone signed an $18 million deal with privately held Zenyaku Kogyo of Japan to find and produce such antibodies last year.

SOURCE: Proceedings of the National Academy of Sciences, online June 28, 2010.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underFlu

Keep reading

Flu

Uzbekistan says closed Kazakh border due to flu

Uzbekistan said on Wednesday it had closed the border with Central Asian neighbour Kazakhstan as part of a seasonal anti-flu quarantine. On Monday, Kazakhstan said Uzbekistan shut the border without any explanations…

1 min read

Flu

Worst case H1N1 may cut UK economy by 4.3 percent

- A severe H1N1 flu pandemic could cost the UK economy 72 billion pounds ($121 billion), British scientists said on Friday, but advised against closing schools even if the current mild pandemic takes a turn for the…

3 min read

Flu

Canada sees spike in H1N1 flu-related deaths

The H1N1 flu killed more people in Canada during the past week than in any other week this year, but health officials said on Tuesday the nation's vaccination program was going so well that it may reach its peak…

2 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.